MedPath

Research and Application of Ultrasonic Intelligent Diagnosis System for Ovarian Mass

Not yet recruiting
Conditions
Ovarian Neoplasms
Adnexal Mass
Registration Number
NCT06528236
Lead Sponsor
Zhejiang Provincial People's Hospital
Brief Summary

Research on automatic detection of ovarian mass and intelligent auxiliary diagnosis system based on multimodal ultrasound images.

Detailed Description

Investigators aimed to develop an ultrasonic intelligent diagnosis system for ovarian mass based on multimodal ultrasound images.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Female
Target Recruitment
100000
Inclusion Criteria
  1. During gynecological ultrasound examination, at least one patient with persistent ovarian tumor was found.
  2. The patient underwent surgical treatment and the histopathological results.
Exclusion Criteria
  1. Histopathological analysis confirms non-ovarian tumor;
  2. Histopathological results are inconclusive;
  3. Issues with image quality: the ovarian mass is incomplete and does not show some surrounding tissues (but the mass is too large to exclude completely); the images are overly blurry, making it difficult to determine the characteristics of the ovarian mass (possible reasons include hardware quality issues with the ultrasound machine, motion blur, focusing problems, presence of intestinal gas in the patient); gain settings make it difficult to judge the characteristics of the ovarian mass (such as low contrast, excessively dark images, or saturation); the presence of artifacts affects the assessment of ultrasound characteristics of the ovarian mass and should be excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the curveThrough study completion, an average of 1 year

AUC (Area Under the Curve) is a common index used to evaluate the performance of binary classification model.

Secondary Outcome Measures
NameTimeMethod
SensitivityThrough study completion, an average of 1 year

Sensitivity refers to the ability of the test to correctly identify a positive result in an individual who actually has the disease. It represents the proportion of cases in which the test is able to detect a positive for the disease

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.